Skip to main navigation

Skip to Content

Live - Investor Relations & Corporate Menu

Science
News
About
Investors
- Company Presentations
- Financial Information
  - SEC Filings
  - Annual Reports
Patients
We're Hiring
Resources

Sign Up for Alerts Notify Me About Clinical Trials

Publications

Publications

Journal Articles and Publications

PTI-125 Reduces Biomarkers of Alzheimer’s Disease In Patients

Source

Journal of Prevention of Alzheimer’s Disease 2020; DOI: 10.14283

Altered Filamin A Enables Amyloid Beta-induced Tau Hyperphosphorylation and Neuroinflammation in Alzheimer’s Disease

Source

Neuroimmunology and Neuroinflammation 2017;4:263-71

PTI-125 Binds and Reverses an Altered Conformation of Filamin A to Reduce Alzheimer's Disease Pathogenesis

Source

Neurobiology of Aging 2017; 55:99-114.

Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A

Source

Journal of Neuroscience 2012; 32:9773-84.

Shareholder Tools - ACTIVE

Print Page

Sign Up for Alerts

Notify Me About Clinical Trials

RSS News Feeds

Contact Us

© 2021 Cassava Sciences, Inc.

Live - Investor Relations & Corporate Menu

Science
News
About
Investors
Patients
We're Hiring
Resources